What Researchers Did
Researchers evaluated the effects of hyperbaric oxygen therapy (HBOT) on hematological indices and biochemical parameters in 103 male patients with diabetic foot treated at a single hospital.
What They Found
After HBOT, significant changes (P < .05) were observed in hematological parameters, including decreases in WBC, neutrophils, monocytes, and platelets, and increases in lymphocytes, eosinophils, MCHC, and RDW. Biochemical parameters also improved, with significant decreases in glucose, C-reactive protein, direct bilirubin, and total protein levels (P < .05). Negative correlations were noted between HBOT sessions and MCH (P = .037) and BUN (P = .037).
What This Means for Canadian Patients
For Canadian patients with diabetic foot, these findings suggest that hyperbaric oxygen therapy may offer beneficial effects on blood parameters and inflammation markers. This could potentially contribute to better overall management and healing outcomes for this complex condition.
Canadian Relevance
This study has no direct Canadian connection as it was conducted at a single hospital outside of Canada.
Study Limitations
A significant limitation of this study is its retrospective design, reliance on file records, and inclusion of only male patients from a single center.